Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome

Table 3

Multiple regression model of study biomarkers and their relation with indicators of carotid atherosclerosis in observed CKD and PD patients.

		SE	Beta		value	CI 95%; lower–higher
MDA (ng/mL)	0.005	0.001	0.675	6.595	0.000	0.004–0.007
MMP-9 (ng/mL)	0.001	0.000	0.254	2.480	0.017	0.000–0.001
Dependent variable: IMT
MDA (ng/mL)	0.029	0.004	0.683	6.941	0.000	0.020–0.037
MMP-9 (ng/mL)	0.003	0.001	0.255	2.592	0.013	0.001–0.005
Dependent variable: plaque score

SE: standard error; CI: confidence interval: IMT: intima media thickness; MDA: malondialdehyde; MMP-9: matrix metalloproteinase-9.